Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Humana
HUM
$45.8B
| $42.4M | 0.06% |
159,220
-343,846
| -68% | -$99.1M |
|
402
RingCentral
RNG
$4.3B
| $42.1M | 0.06% |
390,262
-435,894
| -53% | -$42.8M |
|
403
United Rentals
URI
$69.8B
| $42.1M | 0.06% |
368,228
+73,465
| +25% | +$9.07M |
|
404
Brighthouse Financial
BHF
$3.64B
| $41.9M | 0.06% |
1,153,335
+1,137,189
| +7,043% | +$42.6M |
|
405
Sherwin-Williams
SHW
$80B
| $41.8M | 0.06% |
291,459
-1,136,874
| -80% | -$158M |
|
406
Puma Biotechnology
PBYI
$413M
| $41.8M | 0.06% |
1,078,404
-254,292
| -19% | -$7.77M |
|
407
Iron Mountain
IRM
$37.4B
| $41.8M | 0.06% |
1,179,287
+1,166,635
| +9,221% | +$41.2M |
|
|
RETA
408
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $41.8M | 0.06% |
488,925
+353,267
| +260% | +$29.3M |
|
409
Bio-Techne
TECH
$11.2B
| $41.7M | 0.06% |
840,124
+826,876
| +6,242% | +$37.2M |
|
410
Pacira BioSciences
PCRX
$1.03B
| $41.6M | 0.06% |
1,093,703
-130,811
| -11% | -$5.11M |
|
411
NiSource
NI
$22.3B
| $41.6M | 0.06% |
1,451,714
-4,058,269
| -74% | -$109M |
|
412
Carter's
CRI
$1.42B
| $41.6M | 0.06% |
412,374
-284,812
| -41% | -$25.4M |
|
413
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.4B
| $41.5M | 0.06% |
967,200
-1,106,000
| -53% | -$46.5M |
|
414
Newell Brands
NWL
$2.25B
| $41.3M | 0.06% |
2,692,796
-1,088,682
| -29% | -$20M |
|
|
ABMD
415
DELISTED
Abiomed Inc
ABMD
| $41.1M | 0.06% |
143,995
+73,787
| +105% | +$24.5M |
|
416
Popular Inc
BPOP
$11B
| $40.8M | 0.06% |
782,515
-505,833
| -39% | -$26.9M |
|
|
ZNGA
417
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $40.6M | 0.06% |
7,611,026
-109,766
| -1% | -$528K |
|
418
Fortinet
FTNT
$113B
| $40.5M | 0.06% |
2,409,455
-6,036,320
| -71% | -$96.2M |
|
419
Corpay
CPAY
$24.7B
| $40.5M | 0.06% |
164,063
+15,953
| +11% | +$3.45M |
|
420
Tyler Technologies
TYL
$12.9B
| $40.4M | 0.06% |
197,808
+190,254
| +2,519% | +$37.7M |
|
421
UDR
UDR
$12.8B
| $40.3M | 0.06% |
886,627
+77,992
| +10% | +$3.39M |
|
|
FLIR
422
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $40.3M | 0.06% |
847,113
+350,804
| +71% | +$17M |
|
423
Cousins Properties
CUZ
$5.31B
| $40.3M | 0.06% |
1,042,471
+776,953
| +293% | +$28.4M |
|
424
Cannae Holdings
CNNE
$656M
| $40.3M | 0.06% |
1,659,753
+1,314,537
| +381% | +$27.7M |
|
|
RP
425
DELISTED
RealPage, Inc.
RP
| $40.2M | 0.06% |
663,042
+265,692
| +67% | +$15.2M |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.